ME

Matthias Eder

DK Deutsches Krebsforschungszentrum: 2 patents #1 of 39Top 3%
NA Novartis Ag: 2 patents #28 of 511Top 6%
RH Ruprecht - Karls - Universität Heidelberg: 1 patents #1 of 20Top 5%
Overall (2024): #47,531 of 561,600Top 9%
4
Patents 2024

Issued Patents 2024

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
12156920 Double-labeled probe for molecular imaging and use thereof Ann-Christin EDER, Klaus Kopka, Martin Schaefer, Ulrike Bauder-Wuest, Uwe Haberkorn 2024-12-03
12054458 18F-tagged inhibitors of prostate specific membrane antigen (PSMA) and their use as imaging agents for prostate cancer Jens Cardinale, Martin Schaefer, Klaus Kopka, Ulrike Bauder-Wuest, Michael Eisenhut +3 more 2024-08-06
11951190 Use of labeled inhibitors of prostate specific membrane antigen (PSMA), as agents for the treatment of prostate cancer Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Michael Eisenhut, Walter Mier +1 more 2024-04-09
11931430 Labeled inhibitors of prostate specific membrane antigen (PSMA) as agents for the treatment of prostate cancer Klaus Kopka, Martin SCHÄFER, Ulrike BAUDER-WÜST, Michael Eisenhut, Walter Mier +1 more 2024-03-19